Uncategorized

American Exceptionalism

“The multiculturalism movement must be unmasked for the fraud that it is. There are superior cultures, and ours is one of them.”-Mitt Romney A quick look at the Republican presidential candidates for 2012 will reveal a very clear theme: American Exceptionalism. Romney, Gingrich, Bachman. You’d be hard pressed to find a candidate who does not … Continue reading

Uncategorized

DC Residents Dishonest?

As a Midwesterner, I was not surprised that Chicago ranked first in “honesty” in the social experiment/PR ploy recently conducted by Honest Tea. As someone who has lived in DC for 9 years, our capital’s third-to-last ranking didn’t surprise me much either. From my favorite local real estate blog Urban Turf: “On Tuesday, Honest Tea … Continue reading

Uncategorized

Markets and Healthcare

One of the great academic accomplishments of our time is our understanding of markets. They are powerful. They can enable human beings to make the most of scarce resources. I believe in having a market economy. Now let me add a caveat. While I do believe in markets, I also acknowledge market failures (externalities, monopolies, … Continue reading

Uncategorized

Problems in Our National Parks.

NPR recently published an article on Yosemite National Park and its problem with ticket scalpers.  Because of a limited number of campsites—only about 400—reservations for campsites are sold online for $20 a night.  Reservations usually sell out within the hour of becoming available, and park rangers suspect ticket scalpers are purchasing large amounts of tickets … Continue reading

Uncategorized

EPA’s New Ozone Rulemakings: More Harmful than Helpful?

Praised by environmentalists and panned by business groups, EPA’s recent rulemakings for ground-level ozone is causing quite the stir.  The rule proposes to cut the national ambient air-quality standard to between 60 and 70 parts per billion (ppb) of allowable ozone.  The current level is 75 ppb. The Washington Times cited the possible damaging effects … Continue reading

Uncategorized

Patients vs. Data

In a recent hearing on the reauthorization of PDUFA (Prescription Drug User Fee Act), concerns were raised about the FDA’s decision to revoke the approval of Avastin for use in the treatment of advanced breast cancer. Several congressmen gave heartfelt anecdotes of relatives or friends whose lives were improved or lengthened through the use of … Continue reading